Analystreport

Cara Therapeutics Inc (NASDAQ: CARA) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Cara Therapeutics, Inc.  (CARA) 
Last cara therapeutics, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.caratherapeutics.com/investor-relations